We are live on ! Find out more

276 hedge funds and large institutions have $7.68B invested in DexCom in 2018 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 93 increasing their positions, 88 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

29% more capital invested

Capital invested by funds: $5.96B → $7.68B (+$1.72B)

23% more call options, than puts

Call options by funds: $27.4M | Put options by funds: $22.4M

14% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 43

1% more funds holding

Funds holding: 273276 (+3)

6% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 88

1.87% less ownership

Funds ownership: 477.97%476.1% (-1.9%)

Holders
276
Holders Change
+3
Holders Change %
+1.1%
% of All Funds
6.33%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
49
Increased
93
Reduced
88
Closed
43
Calls
$27.4M
Puts
$22.4M
Net Calls
+$5.05M
Net Calls Change
-$11.3M
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$662M -$62.5M -4,228,892 -11%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$544M +$55.2M +3,735,832 +15%
Vanguard Group
3
Vanguard Group
Pennsylvania
$530M +$9.14M +617,912 +2%
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$513M -$103M -6,994,932 -20%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$483M -$107M -7,237,756 -22%
Baillie Gifford & Co
6
Baillie Gifford & Co
United Kingdom
$402M -$7.85M -531,040 -2%
Capital World Investors
7
Capital World Investors
California
$390M +$110M +7,440,000 +55%
Morgan Stanley
8
Morgan Stanley
New York
$321M +$20.5M +1,388,648 +9%
BlackRock
9
BlackRock
New York
$288M +$5.2M +351,892 +2%
Brown Advisory
10
Brown Advisory
Maryland
$266M -$8.14M -550,780 -4%
JP Morgan Chase
11
JP Morgan Chase
New York
$192M +$12.5M +845,000 +9%
Axa
12
Axa
France
$144M +$1.59M +107,720 +1%
CS
13
Credit Suisse
Switzerland
$139M +$25.1M +1,695,200 +29%
William Blair Investment Management
14
William Blair Investment Management
Illinois
$138M +$5.7M +385,388 +5%
Goldman Sachs
15
Goldman Sachs
New York
$126M +$8.91M +602,832 +10%
O
16
OppenheimerFunds
New York
$111M -$48.5K -3,280 -0.1%
Mackenzie Financial
17
Mackenzie Financial
Ontario, Canada
$106M +$3.36M +227,180 +4%
Invesco
18
Invesco
Georgia
$95.1M +$114K +7,732 +0.2%
ACH
19
ArrowMark Colorado Holdings
Colorado
$90M +$837K +56,600 +1%
Franklin Resources
20
Franklin Resources
California
$86.7M +$188K +12,732 +0.3%
State Street
21
State Street
Massachusetts
$84.3M -$1.46M -98,464 -2%
Point72 Asset Management
22
Point72 Asset Management
Connecticut
$72.6M +$52M +3,516,700 +879%
Jennison Associates
23
Jennison Associates
New York
$72.5M -$17.8M -1,202,760 -24%
William Blair & Company
24
William Blair & Company
Illinois
$71.1M -$4.08M -275,904 -7%
Millennium Management
25
Millennium Management
New York
$68.9M +$31M +2,093,752 +129%

DXCM Hedge Fund Activity: Q1 2018 in Review

276 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q1 2018, worth a combined $7.68B — up 29% from $5.96B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new DXCM positions and 43 closed out — a net gain of 6 holders — while 93 added to existing stakes and 88 trimmed.

The largest buyer was Capital World Investors, adding an estimated $110M. The largest seller was Wellington Management Group, cutting an estimated $107M.

  • 276 institutional investors held DexCom (DXCM) as of Q1 2018, up from 273 in Q4 2017.
  • Funds reported $7.68B of DexCom stock for Q1 2018, up 29% quarter-over-quarter.
  • 49 funds opened new DexCom positions in Q1 2018 and 43 closed out, a net change of +6 holders.
  • The largest DexCom buyer in Q1 2018 was Capital World Investors, an estimated $110M added.
  • The largest DexCom seller in Q1 2018 was Wellington Management Group, an estimated $107M sold.

Based on aggregated 13F filings for Q1 2018.